Sai Parenteral's Q2 Results FY27: PAT Up 32.7% QoQ to Rs 10.51 Cr, Revenue Rs 194.02 Cr

Sai Parenteral's Ltd (SAIPARENT) Q2 Results FY27 announced on 1 November 2026, covering the company's financial performance for the July to September quarter. The consolidated results report revenue of Rs 194.02 Cr and net profit of Rs 10.51 Cr, and Sai Parenteral's Q2 Results FY27 compare both lines with the previous quarter. The results date of 1 November 2026 anchors every comparison, and each figure traces to the filing made to NSE and BSE.

This results analysis of Sai Parenteral's Q2 Results covers the financial highlights, the business drivers, the outlook and the risks, using Univest data for the quarter. The Financial Highlights table follows directly and sets out the key numbers before the narrative begins.

Click Here – Get Free Investment Predictions

Sai Parenteral's Q2 Results FY27: Financial Highlights

Metric	Q2 FY27 (Sep 26)	Q1 FY27 (Jun 26)	QoQ Change
Revenue	Rs 194.02 Cr	Rs 178.67 Cr	+8.59% QoQ
Operating Profit	Rs 39.34 Cr	Rs 23.52 Cr	+67.26% QoQ
Net Profit (PAT)	Rs 10.51 Cr	Rs 7.92 Cr	+32.7% QoQ

Source: company filing for Sai Parenteral's Q2 Results FY27, 1 November 2026. Figures in Rs Crore, Consolidated basis.

Key Takeaways from Sai Parenteral's Q2 Results: What Stands Out

• Revenue rose 8.59% QoQ to Rs 194.02 Cr from Rs 178.67 Cr in the previous quarter, a steady step up on the consolidated results base.
• Net profit climbed 32.7% QoQ to Rs 10.51 Cr from Rs 7.92 Cr, so profit grew faster than revenue over the same period.
• Operating Profit expanded 67.26% QoQ to Rs 39.34 Cr from Rs 23.52 Cr, the widest swing in Sai Parenteral's Q2 Results FY27 on a percentage basis.
• QoQ growth was positive on all three lines reported, which, measured from the results date of 1 November 2026, gives investors a clean read of direction.
• Return on equity of 4.88% in FY26 is the first risk flag, and the performance analysis below explains how the numbers fit together.

Sai Parenteral's Q2 Results FY27: Performance Analysis

Sai Parenteral's reported consolidated revenue of Rs 194.02 Cr, net profit of Rs 10.51 Cr and Operating Profit of Rs 39.34 Cr for the July to September quarter. Each line is higher than the previous quarter, which makes the quarterly results a broad-based sequential improvement on the numbers supplied.

Revenue added 8.59% QoQ, moving from Rs 178.67 Cr to Rs 194.02 Cr. Net profit rose from Rs 7.92 Cr to Rs 10.51 Cr, a 32.7% QoQ gain, and the gap between the two growth rates shows profit expanded faster than sales. In Sai Parenteral's Q2 Results FY27, that gap is the main feature of the quarter.

Operating Profit rose 67.26% QoQ from Rs 23.52 Cr to Rs 39.34 Cr, the strongest QoQ growth among the reported lines. The supplied data confirms these movements but does not establish a single cause, so investors reading Sai Parenteral's Q2 Results should watch the next disclosures for fuller detail, which is where the results analysis turns to the business factors.

Check the Univest Screener for live results data

Key Business Factors This Quarter

Revenue grew 8.6% quarter on quarter – The results analysis points to revenue as the first business factor. Revenue reached Rs 194.02 Cr in the latest quarter against Rs 178.67 Cr before, and this top-line step is the base on which every other line in the quarterly results rests.

Net profit rose 32.7% quarter on quarter – Net profit reached Rs 10.51 Cr compared with Rs 7.92 Cr in the previous quarter. This is the second factor in Sai Parenteral's Q2 Results FY27, and it shows that more of the revenue growth carried through to the bottom line.

Operating Profit widened 67.26% quarter on quarter – Operating Profit increased from Rs 23.52 Cr to Rs 39.34 Cr. This third factor sits between revenue and net profit, and it explains why QoQ growth in profit outpaced the growth in sales across the quarter.

FY27 Outlook After Sai Parenteral's Q2 Results

The FY27 view rests on arithmetic from the results date onward, and the reported numbers are the only basis for it. Full-year FY27 results will depend on subsequent quarters, and Sai Parenteral's Q2 Results FY27 provide the first consolidated results base for that comparison.

A second look at the net profit trend adds context. Quarterly net profit has ranged from Rs 1.42 Cr to Rs 13.16 Cr over the last 5 quarters, so the Rs 10.51 Cr reported now sits within that band. The results analysis therefore treats the quarter as one data point, and the next section sets out the risks that come with it.

Key Risks to Watch After Sai Parenteral's Q2 Results FY27

Low return on equity

Return on equity was low at 4.88% in FY26. Even with Sai Parenteral's Q2 Results FY27 showing higher profit, that return level remains a reference point for how efficiently equity capital is being used, and investors may track it through later quarters.

High debt

Debt is high at 0.65 times total assets in FY26. A used balance sheet matters alongside QoQ growth in revenue and profit, because it shapes how much of the operating gain stays available to the business after obligations.

Volatile quarterly net profit

Quarterly net profit has been volatile, ranging from Rs 1.42 Cr to Rs 13.16 Cr over the last 5 quarters. A rise to Rs 10.51 Cr is therefore best read alongside earlier quarters rather than on its own.

Download the Univest iOS App or Univest Android App to track quarterly results as they are declared.

Conclusion

Sai Parenteral's Q2 Results FY27 show consolidated revenue of Rs 194.02 Cr and net profit of Rs 10.51 Cr, both higher QoQ. The results analysis shows faster profit growth than sales growth, while risk flags on returns and debt remain. Readers of Sai Parenteral's Q2 Results should consult a SEBI-registered advisor before acting.

Frequently Asked Questions on Sai Parenteral's Q2 Results FY27

What are Sai Parenteral's Q2 Results FY27?

Ans. Sai Parenteral's Q2 Results FY27 are the consolidated quarterly results for July to September 2026, with revenue of Rs 194.02 Cr and net profit of Rs 10.51 Cr, as covered in the Quick Answer section above.

What is the results date for Sai Parenteral's Q2 Results FY27?

Ans. The results date for Sai Parenteral's Q2 Results FY27 is 1 November 2026, when Sai Parenteral's declared its results, which means every figure in the Financial Highlights table comes from that filing.

What revenue was reported in Sai Parenteral's Q2 Results FY27?

Ans. Sai Parenteral's reported consolidated revenue of Rs 194.02 Cr in Sai Parenteral's Q2 Results FY27, compared with Rs 178.67 Cr in the previous quarter, as shown in the Financial Highlights table.

What net profit was reported in Sai Parenteral's Q2 Results FY27?

Ans. Net profit in Sai Parenteral's Q2 Results FY27 was Rs 10.51 Cr, compared with Rs 7.92 Cr in the previous quarter, which means net profit grew faster than revenue, as the performance analysis explains.

How much QoQ growth did revenue show in Sai Parenteral's Q2 Results FY27?

Ans. Revenue showed QoQ growth of 8.59% in Sai Parenteral's Q2 Results FY27, rising to Rs 194.02 Cr from Rs 178.67 Cr, while the Key Takeaways section places this alongside the profit moves.

Did net profit rise or fall in Sai Parenteral's Q2 Results?

Ans. Net profit rose 32.7% QoQ in Sai Parenteral's Q2 Results, from Rs 7.92 Cr to Rs 10.51 Cr, which means the bottom line outpaced revenue growth, as the performance analysis section shows.

What was the Operating Profit in Sai Parenteral's Q2 Results FY27?

Ans. Operating Profit in Sai Parenteral's Q2 Results FY27 was Rs 39.34 Cr, up 67.26% QoQ from Rs 23.52 Cr, while the Key Business Factors section explains how it sits between revenue and net profit.

Are Sai Parenteral's Q2 Results consolidated results or standalone results?

Ans. Sai Parenteral's Q2 Results are consolidated results, as the company reported them on a consolidated basis, so the figures cover the group, and the Quick Answer section states this basis up front.

What business factors shaped Sai Parenteral's Q2 Results FY27?

Ans. Revenue growth of 8.6%, net profit growth of 32.7% and the Operating Profit widening of 67.26% shaped Sai Parenteral's Q2 Results FY27, alongside the detail given in the Key Business Factors section.

What are the key risks after Sai Parenteral's Q2 Results FY27?

Ans. The risks after Sai Parenteral's Q2 Results FY27 are return on equity of 4.88% in FY26, debt at 0.65 times total assets, and volatile quarterly net profit, as the Key Risks section explains.

What is the outlook after Sai Parenteral's Q2 Results?

Ans. After Sai Parenteral's Q2 Results, FY27 full-year results will depend on subsequent quarters, which is why the Outlook section stays limited to the reported numbers and the disclosed trend.

Where can I find the complete Sai Parenteral's Q2 Results FY27 data?

Ans. The complete Sai Parenteral's Q2 Results FY27 data is in the Financial Highlights table above, and the Univest Screener and Univest app let readers compare the quarterly results with earlier periods.